SCOLR Pharma, Inc. Announces Extension of Research Agreement with Consumer Products Company to Co-Develop Novel Application of its CDT(R) Delivery Platform

BELLEVUE, Wash.--(BUSINESS WIRE)--SCOLR Pharma, Inc. (AMEX: DDD) today announced an extension of its research agreement with a global consumer products company to co-develop a novel application of its CDT® drug delivery technology.